Books

  1. Mayumi Ueta: Stevens-Johnson syndrome with ocular complication. biopharmaceutics and drug hypersensitivity. Paul Mossillo & John Pinzini editors, p129-150. Nova Science Publishers, Inc, NY, 2010.
  2. Mayumi Ueta: Ethnic differences in the association of HLA and SJS. European Ophthalmic Review vol3 issue 1, p15-18. Touch Briefings, London, 2009.

Discourse

  1. Ueta M. Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications.Front Med (Lausanne). 8:651247, 2021.
  2. Wakamatsu TH, Ueta M, Inoue C, Costa KA, Sakano LY, Sallum JM, Gomes JÁ, Kinoshita S. Human Leukocyte Antigen Class I and II Genes Associated with Dipyrone-Related Stevens-Johnson Syndrome and Severe Ocular Complications in a Brazilian Population. Ocul Surf. 20:173-175, 2021.
  3. Kinoshita F, Yokota I, Mieno H, Ueta M, Bush J, Kinoshita S, Sueki H, Asada H, Morita E, Fukushima M, Sotozono C, Teramukai S. Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.; Japanese Research Committee on Severe Cutaneous Adverse Reaction. PLoS One. 16(12): e0260730, 2021.
  4. Kinoshita S, Ueta M. Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Front Med (Lausanne). 8:811570, 2021.
  5. Ueta M.Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications.Front Med (Lausanne). 8:649661. 2021.
  6. Ueta M. Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications.Front Med (Lausanne). 8:651247, 2021.
  7. Komai S，Inatomi T，Nakamura T，Ueta M，Horiguchi G，Teramukai S，Kimura Y，Kagimura T，Fukushima M，Kinoshita S，Sotozono C．Long-term outcome of cultivated oral mucosal epithelial transplantation for fornix reconstruction in chronic cicatrising diseases.Br J Ophthalmol．(): ，2021．in press
  8. Itoi M，Higashihara H，Yamagishi K，Hyakutake Y，Okahisa T，Matui F，Nakayama T，Sotozono C．Thermokeratoplasty for Keratoconus: A More Than 30-Year Follow-Up Study．Cornea．(): ，2021．in press.
  9. Ueta M，Hosomi K，Park J，Mizuguchi K，Sotozono C，Kinoshita S，Kunisawa J．Categorization of the Ocular Microbiome in Japanese Stevens-Johnson Syndrome Patients With Severe Ocular Complications．Front Cell Infect Microbiol. 11: 741654, 2021．
  10. Ueta M，Nishigaki H，Mizushima K，Naito Y，Sotozono C，Kinoshita S．Regulation of innate immune response by miR-628-3p upregulated in the plasma of Stevens-Johnson syndrome patients．Ocul Surf. 21: 174-177, 2021．
  11. Mieno H，Ueta M，Kinoshita F，Teramukai S，Kinoshita S，Sotozono C．Corticosteroid Pulse Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Patients With Acute Ocular Involvement．Am J Ophthalmol．231: 194-199, 2021．
  12. Sotozono C，Ueta M，Kinoshita S．Japan: Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications．Front Med (Lausanne). 8: 657327, 2021．
  13. Kawai Y，Hitomi Y，Ueta M，Khor SS，Nakatani K，Sotozono C，Kinoshita S，Nagasaki M，Tokunaga K．Mapping of susceptible variants for cold medicine-related Stevens–Johnson syndrome by whole-genome resequencing． NPJ Genom Med. 6(1):9, 2021.
  14. Butt GF, Hassan A, Wallace GR, Kinoshita S, Ahmad S, Ueta M, Rauz S. Human leukocyte antigen B*0702 is protective against ocular Stevens-Johnson syndrome/toxic epidermal necrolysis in the UK population. Sci Rep. 11(1):2928, 2021.
  15. Ma KS, Chung WH, Hsueh YJ, Chen SY, Tokunaga K, Kinoshita S, Ma DHK, Ueta M. Human leucocyte antigen association of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications in Han Chinese. Br J Ophthalmol. bjophthalmol-2020-317105, 2021.
  16. Sunaga Y, Kurosawa M, Ochiai H, Watanabe H, Sueki H, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Hama N, Abe R, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Kokaze A. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018. J Dermatol Sci. 100(3):175-182, 2020.
  17. Itoi M, Ueta M, Ogino K, Sumi E, Imai K, Teramukai S, Kinoshita S, Sotozono C. Clinical trial to evaluate the therapeutic benefits of limbal-supported contact lens wear for ocular sequelae due to Stevens-Johnson syndrome/toxic epidermal necrolysis. Cont Lens Anterior Eye. 43(6):535-542, 2020.
  18. Jongkhajornpong P, Ueta M, Lekhanont K, Puangsricharern V, Prabhasawat P, Chantaren P, Pisuchpen P, Kinoshita S. Association of HLA polymorphisms and acetaminophen-related Steven-Johnson syndrome with severe ocular complications in Thai population. Br J Ophthalmol. bjophthalmol-2020-317315, 2020.
  19. Yoshikawa Y, Ueta M, Nishigaki H, Kinoshita S, Ikeda T, Sotozono C. Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis. Sci Rep. 10(1):18922, 2020.
  20. Sotozono C, Inatomi T, Nakamura T, Ueta M, Imai K, Fukuoka H, Komai S, Ishida G, Kitazawa K, Yokoi N, Koizumi N, Kimura Y, Go M, Fukushima M, Kinoshita S. Oral Mucosal Epithelial Transplantation and Limbal-Rigid Contact Lens: A Therapeutic Modality for the Treatment of Severe Ocular Surface Disorders. Cornea. 39 Suppl 1: S19-S27, 2020.
  21. Ueta M, Nishigaki H, Sotozono C, Yokoi N, Mizushima K, Naito Y, Kinoshita S. Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage. Sci Rep. 10(1):17239, 2020.
  22. Tangamornsuksan W, Chanprasert S, Nadee P, Rungruang S, Meesilsat N, Ueta M, Lohitnavy M. HLA genotypes and cold medicine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications: a systematic review and meta-analysis. Sci Rep. 10(1):10589, 2020.
  23. Chang WC, Abe R, Anderson P, Anderson W, Ardern-Jones MR, Beachkofsky TM, Bellón T, Biala AK, Bouchard C, Cavalleri GL, Chapman N, Chodosh J, Choi HK, Cibotti RR, Divito SJ, Dewar K, Dehaeck U, Etminan M, Forbes D, Fuchs E, Goldman JL, Holmes JH 4th, Hope EA, Hung SI, Hsieh CL, Iovieno A, Jagdeo J, Kim MK, Koelle DM, Lacouture ME, Le Pallec S, Lehloenya RJ, Lim R, Lowe A, McCawley J, McCawley J, Micheletti RG, Mockenhaupt M, Niemeyer K, Norcross MA, Oboh D, Olteanu C, Pasieka HB, Peter J, Pirmohamed M, Rieder M, Saeed HN, Shear NH, Shieh C, Straus S, Sukasem C, Sung C, Trubiano JA, Tsou SY, Ueta M, Volpi S, Wan C, Wang H, Wang ZQ, Weintraub J, Whale C, Wheatley LM, Whyte-Croasdaile S, Williams KB, Wright G, Yeung SN, Zhou L, Chung WH, Phillips EJ, Carleton BC. SJS/TEN 2019: From science to translation. J Dermatol Sci. 98(1):2-12, 2020.
  24. Mieno H, Ueta M, Yamada K, Yamanaka Y, Nakayama T, Watanabe A, Kinoshita S, Sotozono C. Expression of prostaglandin E2 receptor 3 in the eyelid epidermis of patients with Stevens- Johnson syndrome/toxic epidermal necrolysis. Br J Ophthalmol. 104 (7): 1022-1027, 2020.
  25. Yoshikawa Y, Ueta M, Fukuoka H, Inatomi T, Yokota I, Teramukai S, Yokoi N, Kinoshita S, Tajiri K, Ikeda T, Sotozono C. Long-term Progression of Ocular Surface Disease in Stevens-Johnson Syndrome andToxic Epidermal Necrolysis. Cornea. 39(6): 745-753, 2020.
  26. Ueta M. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications. Expert Rev Clin Immunol. 16(3):285-291, 2020.
  27. Kaneko Y, Seko Y, Sotozono C, Ueta M, Sato S, Shimamoto T, Iwasaku M, Yamada T, Uchino J, Hizawa N, Takayama K. Respiratory complications of Stevens-Johnson syndrome (SJS): 3 cases of SJS-induced obstructive bronchiolitis. Allergol Int. 69(3):465-467, 2020.
  28. Chantaren P, Jongkhajornpong P, Ueta M, Puangsricharern V, Lekhanont K, Pisuchpen P, Prabhasawat P, Suphapeetiporn K, Kinoshita S. Association of IKZF1 SNPs in cold medicine-related Stevens-Johnson syndrome in Thailand. Clin Transl Allergy. 9:61, 2019.
  29. Shrestha T, Moon HS, Choi W, Yoon HJ, Ji YS, Ueta M, Yoon KC. Characteristics of meibomian gland dysfunction in patients with Stevens-Johnson syndrome. Medicine (Baltimore). 98(26):e16155, 2019.
  30. Nakae M, Tamagawa-Mineoka R, Masuda K, Ueta M, Sotozono C, Katoh N. Stevens‐Johnson syndrome and toxic epidermal necrolysis cases treated at our hospital over the past 10 years. Journal of Cutaneous Immunology and Allergy. 2(1): 25-30, 2019.
  31. Nakatani K, Ueta M, Khor SS, Hitomi Y, Okudaira Y, Masuya A, Wada Y, Sotozono C, Kinoshita S, Inoko H, Tokunaga K. Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing. Sci Rep. 9(1): 16240, 2019.
  32. Ueta M, Nakamura R, Saito Y, Tokunaga K, Sotozono C, Yabe T, Aihara M, Matsunaga K, Kinoshita S. Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens-Johnson syndrome with severe ocular complications in Japanese individuals. Hum Genome Var. 6: 50, 2019.
  33. Ueta M, Sotozono C, Nishigaki H, Ohsako S, Yokoi N, Mizushima K, Naito Y, Kinoshita S. Gene expression analysis of conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage. BMJ Open Ophthalmol. 4(1): e000254, 2019.
  34. Jun I, Rim JH, Kim MK, Yoon KC, Joo CK, Kinoshita S, Seo KY, Ueta M. Association of human antigen class I genes with cold medicine-related Stevens-Johnson syndrome with severe ocular complications in a Korean population. Br J Ophthalmol. Br J Ophthalmol. 103(4):573-576, 2019. Epub 2019 Jan 31
  35. Yoon HJ, Kim MK, Seo KY, Ueta M, Yoon KC.　Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bev cizumab for corneal neovascularization in Stevens-Johnson syndrome. Int Ophthalmol. 39(1):55-62, 2019. Epub 2017 Dec 18.
  36. Sotozono C, Ueta M, Yokoi N.　Severe Dry Eye With Combined Mechanisms is Involved in the Ocular Sequelae of SJS/TEN at the Chronic Stage.　Invest Ophthalmol Vis Sci. 59(14):DES80-DES86, 2018.
  37. Su SC, Chen CB, Chang WC, Wang CW, Fan WL, Lu LY, Nakamura R, Saito Y, Ueta M, Kinoshita S, Sukasem C, Yampayon K, Kijsanayotin P, Nakkam N, Saksit N, Tassaneeyakul W, Aihara M, Lin YJ, Chang CJ, Wu T, Hung SI, Chung WH. HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians. Clin Pharmacol Ther. 105(2):476-485, 2019. Epub 2018 Sep 30.
  38. Jongkhajornpong P, Lekhanont K, Pisuchpen P, Chantaren P, Puangsricharern V, Prabhasawat P, Suphapeetiporn K, Kinoshita S, Ueta M. Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand. Br J Ophthalmol. 102(9):1303-1307, 2018.
  39. Lee HK, Yoon KC, Seo KY, Ueta M, Kim MK. Chronic ocular complications of Stevens-Johnson syndrome associated with causative medications in Korea. J Allergy Clin Immunol Pract. 6(2):700-702.e2, 2018.　
  40. Ueta M, Hamuro J, Nishigaki H, Nakamura N, Shinomiya K, Mizushima K, Hitomi Y, Tamagawa-Mineoka R, Yokoi N, Naito Y, Tokunaga K, Katoh N, Sotozono C, Kinoshita S. Mucocutaneous inflammation in the Ikaros Family Zinc Finger 1-keratin 5-specific transgenic mice. Allergy. 73(2): 395-404, 2018.
  41. Kannabiran C, Ueta M, Sangwan V, Rathi V, Basu S, Tokunaga K, Kinoshita S. Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population. Sci Rep. 7(1):15960, 2017.
  42. Jain R, Sharma N, Basu S, Iyer G, Ueta M, Sotozono C, Kannibiran C, Rathi VM, Gupta N, Kinoshita S, Gomes JA, Chodosh J, Sangwan VS. Reply: Amniotic membrane transplantation in Stevens-Johnson Syndrome. Surv Ophthalmol. Surv Ophthalmol. 62(2):249-250, 2017.
  43. Ueta M, Nishigaki H, Sotozono C, Kinoshita S.Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage. BMJ Open Ophthalmol. 1(1): e000073, 2017
  44. Ueta M, Sawai H, Shingaki R, Kawai Y, Sotozono C, Kojima K, Yoon KC, Kim MK, Seo KY, Joo CK, Nagasaki M, Kinoshita S, Tokunaga K. Genome-wide association study using the ethnicity-specific Japonica array: identification of new susceptibility loci for cold medicine-related Stevens-Johnson syndrome with severe ocular complications. J Hum Genet. 62(4): 485-489, 2017.
  45. Wakamatsu TH, Ueta M, Tokunaga K, Okada Y, Loureiro RR, Costa KA, Sallum JM, Milhomens JA, Inoue C, Sotozono C, Gomes JÁ, Kinoshita S. Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population. JAMA Ophthalmol. 135(4): 355-360, 2017.
  46. Lee HS, Ueta M, Kim MK, Seo KY, Sotozono C, Kinoshita S, Yoon KC. Analysis of Ocular Manifestation and Genetic Association of Allopurinol-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in South Korea. Cornea. 35(2): 199-204, 2016.
  47. Saito K, Ueta M, Maekawa K, Sotozono C, Kinoshita S, Saito Y. Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens Johnson Syndrome/Toxic Epidermal Necrolysis. PLoS One. 11(11): e0167402, 2016.
  48. Kohanim S，Palioura S，Saeed HN，Akpek EK，Amescua G，Basu S，Blomquist PH，Bouchard CS，Dart JK，Gai X，Gomes JA，Gregory DG，Iyer G，Jacobs DS，Johnson AJ，Kinoshita S，Mantagos IS，Mehta JS，Perez VL，Pflugfelder SC，Sangwan VS，Sippel KC，Sotozono C，Srinivasan B，Tan DT，Tandon R，Tseng SC，Ueta M，Chodosh J. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. I. Systemic Disease.Ocul Surf. 2016 Jan;14(1):2-19. Review.
  49. Jain R，Sharma N，Basu S，Iyer G，Ueta M，Sotozono C，Kannibiran C，Rathi VM，Gupta N，Kinoshita S，Gomes JA，Chodosh J，Sangwan VS. Stevens Johnsons Syndrome: The Role of an Ophthalmologist. Surv Ophthalmol. 61(4):369-99, 2016 IF=3.374)
  50. Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, Blomquist PH, Bouchard CS, Dart JK, Gai X, Gomes JA, Gregory DG, Iyer G, Jacobs DS, Johnson AJ,Kinoshita S, Mantagos IS, Mehta JS, Perez VL, Pflugfelder SC, Sangwan VS, Sippel KC, Sotozono C, Srinivasan B, Tan DT, Tandon R, Tseng SC, Ueta M, Chodosh J.　Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/ToxicEpidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II.Ophthalmic Disease. Ocul Surf. 4(2): 168-88, 2016.
  51. Sotozono C, Ueta M, Nakatani E, Kitami A, Watanabe H, Sueki H, Iijima M, Aihara M, Ikezawa Z, Aihara Y, Kano Y, Shiohara T, Tohyama M, Shirakata Y, Kaneda　H, Fukushima M, Kinoshita S, Hashimoto K; Japanese Research Committee on Severe Cutaneous Adverse Reaction. Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Am J Ophthalmol. 160(2): 228-237, 2015.
  52. Kaniwa N, Ueta M, Nakamura R, Okamoto-Uchida Y, Sugiyama E, Maekawa K, Takahashi Y, Furuya H, Yagami A, Matsukura S, Ikezawa Z, Matsunaga K, Tokunaga K, Sotozono C, Aihara M, Kinoshita S, Saito Y. Drugs causing severe ocular surface involvements in Japanese patients with StevenseJohnson syndrome/toxic epidermal necrolysis. Allergol Int. 64(4): 379-81, 2015.
  53. Ueta M, Sawai H, Sotozono C, Hitomi Y, Kaniwa N, Kim MK, Seo KY, Yoon KC, Joo CK, Kannabiran C, Wakamatsu TH, Sangwan V, Rathi V, Basu S, Ozeki T, Mushiroda T, Sugiyama E, Maekawa K, Nakamura R, Aihara M, Matsunaga K, Sekine A, Pereira Gomes J, Hamuro J, Saito Y, Kubo M, Kinoshita S, Tokunaga K. IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement. J Allergy Clin Immunol. 135(6): 1538-45, 2015.
  54. Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, Iijima M, Morita E, Niihara H, Asada H, Kabashima K, Azukizawa H, Hashizume H, Nagao K, Takahashi H, Abe R, Sotozono C, Kurosawa M, Aoyama Y, Chu CY, Chung WH, Shiohara T. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). J Dermatol. 42(3): 276-282, 2015.
  55. Ueta M. Genetic Predisposition to Stevens-Johnson Syndrome With Severe Ocular Surface Complications. Cornea. 2015 Nov;34 Suppl 11: S158-65, 2015.
  56. Jongkhajornpong P，Lekhanont K，Ueta M，Kitazawa K，Kawasaki S, Kinoshita S. Novel TACSTD2 mutation in gelatinous drop-like corneal dystrophy. Human Genome Variation 2. 2:15047, 2015.
  57. Maekawa K，Nakamura R，Kaniwa N，Mizusawa S，Kitamoto A，Kitamoto T，Ukaji M， Matsuzawa Y，Sugiyama E，Uchida Y，Kurose K，Ueta M，Sotozono C，Ikeda H，Yagami A，Matsukura S，Kinoshita S，Muramatsu M，Ikezawa Z, Sekine A，Furuya H，Takahashi Y，Matsunaga K，Aihara M，Saito Y; Japan Pharmacogenomics Data Science Consortium. Development of a simple genotyping method for the HLA-A*31:01-tagging SNP in Japanese. Pharmacogenomics. 16(15):1689-99, 2015.
  58. Ueta M，Tokunaga K, Sotozono C，Sawai H，Yoon KC，Kim MK，Seo KY，Joo CK，Tashiro K, Kinoshita S. HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens–Johnson syndrome with severe ocular complications. Human Genome Variation 2. 2:15023, 2015.
  59. Sotozono C, Yamauchi N, Maeda S, Kinoshita S. Tear Exchangeable Limbal Rigid Contact Lens for Ocular Sequelae Due to Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis. Am J Ophthalmol. 158(5): 983-93, 2014.
  60. Kim DH, Yoon KC, Seo KY, Lee HS, Yoon SC, Sotozono C, Ueta M, Kim MK. The Role of Systemic Immunomodulatory Treatment and Prognostic Factors on Chronic Ocular Complications in Stevens-Johnson Syndrome.　Ophthalmology. 2014 Sep 24
  61. Ueta M, Kannabiran C, Wakamatsu TH, Kim MK, Yoon KC, Seo KY, Joo CK, Sangwan V, Rathi V, Basu S, Shamaila A, Lee HS, Yoon S, Sotozono C, Gomes JÁ, Tokunaga K, Kinoshita S. Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications. Sci Rep. 2014;4:5981.
  62. Ueta M, Kaniwa N, Sotozono C, Tokunaga K, Saito Y, Sawai H, Miyadera H, Sugiyama E, Maekawa K, Nakamura R, Nagato M, Aihara M, Matsunaga K, Takahashi Y, Furuya H, Muramatsu M, Ikezawa Z, Kinoshita S.Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement. Sci Rep. 2014;4:4862.
  63. Yamada K, Ueta M, Sotozono C, Yokoi N, Inatomi T, Kinoshita S. Upregulation of Toll-like receptor 5 expression in the conjunctival epithelium of various human ocular surface diseases. Br J Ophthalmol. 2014;98:1116-9.
  64. Sotozono C, Inatomi T, Nakamura T, Koizumi N, Yokoi N, Ueta M, Matsuyama K, Kaneda H, Fukushima M, Kinoshita S. Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity. Acta Ophthalmol. 2014;92:e447-53.
  65. Watanabe A, Sotozono C, Ueta M, Katsuhiko Shinomiya, Kinoshita S, Kakizaki H, Selva D, FRANZCO F. Folliculitis in Clinically “Quiet” Chronic Stevens-Johnson syndrome. Ophthal Plast Reconstr Surg. 2014, 30:80-2.
  66. Kaniwa N, Sugiyama E, Saito Y, Kurose K, Maekawa K, Hasegawa R, Furuya H, Ikeda H, Takahashi Y, Muramatsu M, Tohkin M, Ozeki T, Mushiroda T, Kubo M, Kamatani N, Abe M, Yagami A, Ueta M, Sotozono C, Kinoshita S, Ikezawa Z, Matsunaga K, Aihara M. Japan Pharmacogenomics Data Science Consortium. SpecificHLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects.Pharmacogenomics. 14(15):1821-31, 2013.
  67. Ueta M, Sotozono C, Yokoi N, Kinoshita S:　Rebamipide Suppresses PolyI:C-Stimulated Cytokine Production in Human Conjunctival Epithelial Cells. J Ocul Pharmacol Ther. 2013 Sep;29(7):688-93.
  68. Isogai H, Miyadera H, Ueta M, Sotozono C, Kinoshita S, Tokunaga K, Hirayama N. In Silico Risk Assessment of HLA-A*02:06-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Caused by Cold Medicine Ingredients. Journal of Toxicology. Article ID 514068:1-6, 2013.
  69. Tohkin M, Kaniwa N, Saito Y, Sugiyama E, Kurose K, Nishikawa J, Hasegawa R, Aihara M, Matsunaga K, Abe M, Furuya H, Takahashi Y, Ikeda H, Muramatsu M, Ueta M, Sotozono C, Kinoshita S, Ikezawa Z: A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Pharmacogenomics J. 13(1):60-9, 2013.
  70. Kaido M, Yamada M, Sotozono C, Kinoshita S, 他5名. The relation between visual performance and clinical ocular manifestations in Stevens-johnson syndrome. Am J Ophthalmol. 154(3):499-511,2012.
  71. Ueta,M, Tokunaga K, Sotozono C, Sawai H, Tamiya G, Inatomi T, Kinoshita S. HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications. PLoS One. 7(8):e43650, 2012.
  72. Ueta M, Tamiya G, Tokunaga K, Sotozono C, Ueki M, Sawai H, Inatomi T, Matsuoka T, Akira S, Narumiya S, Tashiro K, Kinoshita S: Epistatic interaction between Toll-like receptor 3 (TLR3) and prostaglandin E receptor 3 (PTGER3) genes.　J Allergy Clin Immunol. 2012; 129(5): 1413-1416.e11.
  73. Ueta M, Sotozono C, Yamada K, Yokoi N, Inatomi T, Kinoshita S: Expression of prostaglandin E receptor subtype EP4 in conjunctival epithelium of patients with ocular surface disorders: case-control study. BMJ Open. 2012; 2(5): pii: e001330. doi: 10.1136/bmjopen-2012-001330. Print 2012.
  74. Ueta M: Epistatic interactions associated with stevens-johnson syndrome. Cornea. 2012; Suppl 1:S57-62
  75. Ueta M, Kinoshita S: Ocular surface inflammation is regulated by innate immunity. Prog Retin Eye Res. 2012; 31(6): 551-575.
  76. Ueta M, Sotozono C, Yokoi N, Inatomi T, Kinoshita S: Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface Disorders. PLoS One. 2011; 6(9): e25209.
  77. Watanabe R, Watanabe H, Sotozono C, Kokaze A, Iijima M. Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). Eur J Dermatol. 21(6):889-894, 2011.
  78. Tohkin M, Kaniwa N, Saito Y, Sugiyama E, Kurose K, Nishikawa J, Hasegawa R, Aihara M, Matsunaga K, Abe M, Furuya H, Takahashi Y, Ikeda H, Muramatsu M, Ueta M, Sotozono C, Kinoshita S, Ikezawa Z. A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Pharmacogenomics J. 13(1):60-9, 2011
  79. Yagi T, Sotozono C, Tanaka M, Fuwa M, Sekiyama E, Ueta M, Tashiro K, Kinoshita S. Cytokine storm arising on the ocular surface in a patient with Stevens-Johnson syndrome. Br J Ophthalmol. 95(7): 1030-1031, 2011.
  80. Ueta M, Kinoshita S: Innate immunity of the ocular surface. Brain Res Bull. 2010; 81(2-3): 219-228.
  81. Ueta M, Sotozono C, Nakano M, Taniguchi T, Yagi T, Tokuda Y, Fuwa M, Inatomi T, Yokoi N, Tashiro K, Kinoshita S. Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study. J Allergy Clin Immunol. 126(6):1218-25, 2010.
  82. Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Furuya H,Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R. for the JSAR research group. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxicepidermal necrolysis in Japanese patients. Epilepsia. 51(12): 2461-2465,2010.
  83. Sotozono C, Ueta M, Kinoshita S. Systemic and Local Management at the Onset of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Ocular Complications. Am J Ophthalmol 149(2):354, 2010
  84. Ueta M, Uematsu S, Akira S, Kinoshita S: Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol. 2009; 123(5): 1187-1189.
  85. Ueta M, Matsuoka T, Narumiya S, Kinoshita S: Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol. 2009; 123(2): 466-471.
  86. Sotozono C, Ueta M, Kinoshita S. The Management of Severe Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Arch Dermatol 145(11) : 1336-1337, 2009.
  87. Araki Y,Sotozono C,Inatomi T, Ueta M,Yokoi N,Ueda E,Kishimoto S,Kinoshita S. Successful Treatment of Stevens-Johnson Syndrome with Steroid Pulse Therapy at Disease Onset. Am J Ophthalmol. 147(6):1004-1011, 2009.
  88. Sotozono C, Ueta M, Koizumi N, Inatomi T, Shirakata Y, Ikezawa Z, Hashimoto K, Kinoshita S. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 116(4) : 685-690, 2009.
  89. Ueta M: Innate immunity of the ocular surface and ocular surface inflammatory disorders. Cornea. 2008; 27(Suppl 1):S31-40.
  90. Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Sawada J, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R, JSAR research group. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnsonsyndrome and toxic epidermal necrolysis.Pharmacogenomics. 9(11) :1617-1622, 2008.
  91. Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S. Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome.Br J Ophthalmol 92(7) :989-991, 2008.
  92. Ueta M, Tokunaga K, Sotozono C, Inatomi T,Yabe T, Matsushita M, Mitsuishi Y, Kinoshita S.HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese.Mol Vis 17(14):550-555, 2008.
  93. Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome with ocular surface complications. Invest Ophthalmol Vis Sci. 49(5):1809-1813, 2008
  94. Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S. Association of IL4R polymorphisms with Stevens-Johnson syndrome. J Allergy Clin Immunol. 2007 Dec;120(6):1457-9J Allergy Clin Immunol. 120(6):1457-1459, 2007.
  95. Sotozono C, Ang LP, Koizumi N, Higashihara H, Ueta M, Inatomi T, Yokoi N, Kaido M, Dogru M, Shimazaki J, Tsubota K, Yamada M, Kinoshita S.New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology. 114(7):1294-1302, 2007.
  96. Ueta M, Sotozono , Inatomi T, Kojima K, Tashiro K, Hamuro J, Kinoshita S. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Ophthalmol. 91(7):962-965. 2007.
  97. Ueta M, Sotozono C, Tokunaga K, Yabe T, Kinoshita S. Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese. Am J Ophthalmol. 143(2):367-368, 2007.
  98. Ang LP, Sotozono C, Koizumi N, Suzuki T, Inatomi T, Kinoshita S. A comparison between cultivated and conventional limbal stem cell transplantation for Stevens-Johnson syndrome. Am J Ophthalmol. 143(1):178-180, 2007.
  99. Kaido M, Dogru M, Yamada M, Sotozono C, Kinoshita S, Shimazaki J, Tsubota K. Functional visual acuity in Stevens-Johnson syndrome. Am J Ophthalmol. 142(6):917-922, 2006.
  100. Nakamura T, Ang LPK, Rigby H, Sekiyama E, Inatomi T, Sotozono C, Fullwood NJ, Kinoshita S: The use of autologous serum in the development of Corneal and oral epithelial equivalents in patients with Stevens Johnson syndrome. Invest Ophthalmol Vis Sci. 47(3):909-916, 2006.
  101. Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S: Cultivated Corneal epithelial transplantation for ocular surface reconstruction in acute phase of Stevens-Johnson syndrome. Arch Ophthalmol 119(2): 298-300, 2001.
  102. Kawasaki S, Nishida K, Sotozono C, Quantock AJ, Kinoshita S: Conjunctival inflammation in the chronic phase of Stevens-Johnson syndrome. Br J Ophthalmol 84(10):1191-1193, 2000.